71.9

H. Franklin Bunn

Brigham and Women's Hospital, Harvard University

H. Franklin Bunn's research has significantly advanced our understanding of oxygen delivery and hemoglobin-related disorders. Contributions to the treatment of anemia, sickle cell disease, and other conditions highlight the critical role of increasing oxygen affinity of hemoglobin, targeting hbs polymerization, and identifying novel reductases such as ncb5or. The study of red blood cell size distribution variation and classification of hemoglobin disorders has provided valuable insights into the complexities of these diseases. Moreover, research on pulmonary hypertension, nitric oxide depletion, and hypoxia-inducible factor (HIF) activity has shed light on cellular mechanisms underlying these conditions. These findings have far-reaching implications for the diagnosis, treatment, and prevention of various diseases.

Tumor HypoxiaErythropoiesis-Stimulating AgentsCadmium CarcinogenesisER StressOxygen SensingPulmonary HypertensionSickle-cell DiseaseHypoxia
Firms applying this knowledge

Beam Therapeutics Inc., The University Of Adelaide, University Of Utah Research Foundation, The Kenneth S. Warren Institute, Inc.

Commercial signal 71.9
Scientific signal 73.0
Social signal 68.8
Papers 25
10 Patent-to-paper cites
1,580 Paper cites

scientifiq.ai is an experimental platform. The platform relies on open source data and it may contain errors. Its primary goal is to advance scientific research on innovation.